GlaxoSmithKline has reportedly worked in recent months to shake up its antibiotics business after at least one failed attempt to divest products. Now, dozens of GSK employees could wind up on the cutting room floor as the drugmaker shifts away from producing a key antibiotic component. The British drugmaker will look to trim positions at… Read More »
By Layal Liverpool BCG vaccine (red, lower left) infecting a human white blood cell (green)NIBSC/SCIENCE PHOTO LIBRARY The BCG (Bacillus Calmette-Guérin) tuberculosis vaccine boosts the production of immune cells, which may explain why it can protect newborn babies from dying of sepsis. Previous studies have shown that BCG vaccination can protect newborns against a broad… Read More »
The novel coronavirus pandemic has caused a host of problems in the global pharmaceutical supply chain—particularly in China, a major producer of drug ingredients. Now, seeing an opportunity, India is reportedly working on a plan to supersize its own ingredient manufacturing to combat Chinese dominance in the market. The Indian government is planning to escalate domestic production… Read More »
Mylan is one of a group of drugmakers that have joined the global effort to supply doses of generic hydroxychloroquine, an antimalarial touted as a possible COVID-19 therapy, to ongoing clinical trials. Now, after ramping up production, Mylan is ready to dole out its stockpile faster than expected. After announcing last month it would restart… Read More »
Two chemicals widely used to flavor electronic cigarettes may impair the function of cilia in the human airway, according to a new study led by the Harvard T.H. Chan School of Public Health. Cilia are antennae-like protuberances that are present on 50 percent to 75 percent of the cells that line human airways. They play… Read More »